73554-3111Level 3
Zynteglo (betibeglogene autotemcel)
**Product type:** Cellular Therapy
**Active ingredient:** BETIBEGLOGENE AUTOTEMCEL
**Strength:** 20000000 1/1
**Dosage form:** Suspension
**Route:** Intravenous
**Labeler:** Genetix Biotherapeutics Inc.
**Marketing category:** BLA (BLA125717)
GET
/api/v1/systems/ndc_fda/nodes/73554-3111Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.